Eyelash Extension Drug Receives FDA Approval

eyelashEyelash extensions are one of the latest trends in cosmetic enhancements, a treatment that allows women to forgo their usual mascara routine in order to achieve a more youthful look.

Eyelash extensions are semi-permanent lashes that are attached to the natural lashline using a specialized bonding agents, and the treatment is currently available at many medical spas, day spas and some cosmetic surgery centers around the country.

However, women interested in achieving the celebrity-inspired look of enhanced, voluminous lashes may soon be able to brush on a special hair-growth formula to achieve long-term results, even forgoing surgery and bonding gels altogether.

The FDA has recently approved an eyelash-boosting drug made by Allergan, the same company that makes Botox Cosmetic injections.  The drug is designed to make eyelashes grow longer and fuller, and is expected to reach the consumer market by the middle of 2009.

Allergan will be marketing the drug under the brand name 'LATISSE'. LATISSE is designed to increase the thickness and darkness of the lashes, and also stimulate the hair so that lashes grow longer and fuller.

According to Scott Whitcup M.D., Allergan's Executive Vice President of Research and Development. "Recently, unapproved eyelash products containing active drug ingredients have appeared on the market. If approved, LATISSE™ will offer consumers an FDA-approved product which has been extensively studied in well-controlled clinical trials, is manufactured to pharmaceutical standards, is appropriately labeled for use, and is regulated as a prescription product." (Source:  Allergan Press Release)

The formula will likely be a prescription-only product and made available for those who may have lost their eyelashes due to an accident, or for those who want to stimulate natural eyelash growth.  The product has undergone a number of clinical trials and is still being tested for safety. The price of LATISSE has not yet been disclosed.

Further Reading

RETURN TO BLOG HOME
Advertisement